Pharmaceutical

Cidara gets a nod from Janssen to continue CD388 flu prevention programme

Cidara will also receive $7m in milestone payments for the drug-Fc conjugate as part of the Election to Proceed from Janssen.

Sep 7, 2023 - 20:00
Cidara gets a nod from Janssen to continue CD388 flu prevention programme
Cidara will also receive $7m in milestone payments for the drug-Fc conjugate as part of the Election to Proceed from Janssen.
Read the original article

Tags:

Previous Article

Janssen’s patient programme becomes latest victim of data breach

Next Article

Veracyte and Gustave Roussy announce partnership for cancer therapies

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Lilly wins FDA approval for a weight-loss drug; AstraZeneca enters the race for an obesity pill

STAT+: Pharmalittle: Lilly wins FDA approval for a weig...

Nov 9, 2023

STAT+: Blue Shield of California overhauls drug pricing operation — by adding more vendors

STAT+: Blue Shield of California overhauls drug pricing...

Aug 17, 2023

STAT+: Microsoft strikes partnership with Duke Health to advance AI in medicine

STAT+: Microsoft strikes partnership with Duke Health t...

Aug 1, 2023